Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Preoperative anemia-screening clinics

Yulia Lin

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 570–576.

https://doi.org/10.1182/hematology.2019000061

Published: 2019

Journal Articles

Management of symptoms in polycythemia vera and essential thrombocythemia patients

Deepti Radia, Holly L. Geyer

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 340–348.

https://doi.org/10.1182/asheducation-2015.1.340

Published: 2015

Journal Articles

Diagnosis and management of rare congenital nonimmune hemolytic disease

Patrick G. Gallagher

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 392–399.

https://doi.org/10.1182/asheducation-2015.1.392

Published: 2015

Journal Articles

Sickle solubility test to screen for sickle cell trait: what's the harm?

Venée N. Tubman, Joshua J. Field

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 433–435.

https://doi.org/10.1182/asheducation-2015.1.433

Published: 2015

Journal Articles

Bloodless medicine: what to do when you can't transfuse

Linda M.S. Resar, Steven M. Frank

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 553–558.

https://doi.org/10.1182/asheducation-2014.1.553

Published: 2014

Journal Articles

Smoothing the crescent curve: sickle cell disease

Julie-An Talano, Mitchell S. Cairo

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 468–474.

https://doi.org/10.1182/asheducation-2014.1.468

Published: 2014

Journal Articles

Blood manipulation: current challenges from an anti-doping perspective

Jakob Mørkeberg

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 627–631.

https://doi.org/10.1182/asheducation-2013.1.627

Published: 2013

Journal Articles

Is anti-D immunoglobulin still a frontline treatment option for immune thrombocytopenia?

Jenny M. Despotovic, Cindy E. Neunert

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 283–285.

https://doi.org/10.1182/asheducation-2013.1.283

Published: 2013

Journal Articles

Is there a role for the use of IFN-α in primary myelofibrosis?

Huong (Marie) Nguyen, Jean-Jacques Kiladjian

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 567–570.

https://doi.org/10.1182/asheducation.V2012.1.567.3806899

Published: 2012

Journal Articles

Therapy for Aplastic Anemia

Amy E. DeZern, Eva C. Guinan

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 82–83.

https://doi.org/10.1182/asheducation-2011.1.82

Published: 2011

Journal Articles

Iron Deficiency and Heart Disease: Ironclad Evidence?

Jeffrey L. Carson, John W. Adamson

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 348–350.

https://doi.org/10.1182/asheducation-2010.1.348

Published: 2010

Journal Articles

Anemia of Inflammation

Cindy N. Roy

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 276–280.

https://doi.org/10.1182/asheducation-2010.1.276

Published: 2010

Journal Articles

Evidence-Based Mini-Review: Should Patients Over the Age of 60 with INT-2 or High-Risk Myelodysplastic Syndrome Undergo Allogeneic Stem Cell Transplantation Prior to Progression to Acute Myelogenous Leukemia?

Mark A. Schroeder, William Blum

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 322–324.

https://doi.org/10.1182/asheducation-2010.1.322

Published: 2010

Journal Articles

Alpha thalassemia major—new mutations, intrauterine management, and outcomes

Elliott P. Vichinsky

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 35–41.

https://doi.org/10.1182/asheducation-2009.1.35

Published: 2009

Journal Articles

Appendix: Color Figures

Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 491–506.

https://doi.org/10.1182/asheducation-2008.1.491

Published: 2008

Journal Articles

Mechanisms of Vasculopathy in Sickle Cell Disease and Thalassemia

Claudia R. Morris

Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 177–185.

https://doi.org/10.1182/asheducation-2008.1.177

Published: 2008

Journal Articles

Gene Replacement Therapy for Sickle Cell Disease and Other Blood Disorders

Tim M. Townes

Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 193–196.

https://doi.org/10.1182/asheducation-2008.1.193

Published: 2008

Journal Articles

Hemoglobin E Syndromes

Elliott Vichinsky

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 79–83.

https://doi.org/10.1182/asheducation-2007.1.79

Published: 2007

Journal Articles

Limitations of Clinical Trials in Sickle Cell Disease: A Case Study of the Multi-center Study of Hydroxyurea (MSH) Trial and the Stroke Prevention (STOP) Trial

Michael R. DeBaun, Joshua J. Field

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 482–488.

https://doi.org/10.1182/asheducation-2007.1.482

Published: 2007

Journal Articles

New Insights into Paroxysmal Nocturnal Hemoglobinuria

Robert A. Brodsky

Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 24–28.

https://doi.org/10.1182/asheducation-2006.1.24

Published: 2006

NARROW

Preoperative anemia-screening clinics

Management of symptoms in polycythemia vera and essential thrombocythemia patients

Diagnosis and management of rare congenital nonimmune hemolytic disease

Sickle solubility test to screen for sickle cell trait: what's the harm?

Bloodless medicine: what to do when you can't transfuse

Smoothing the crescent curve: sickle cell disease

Blood manipulation: current challenges from an anti-doping perspective

Is anti-D immunoglobulin still a frontline treatment option for immune thrombocytopenia?

Is there a role for the use of IFN-α in primary myelofibrosis?

Therapy for Aplastic Anemia

Iron Deficiency and Heart Disease: Ironclad Evidence?

Anemia of Inflammation

Evidence-Based Mini-Review: Should Patients Over the Age of 60 with INT-2 or High-Risk Myelodysplastic Syndrome Undergo Allogeneic Stem Cell Transplantation Prior to Progression to Acute Myelogenous Leukemia?

Alpha thalassemia major—new mutations, intrauterine management, and outcomes

Appendix: Color Figures

Mechanisms of Vasculopathy in Sickle Cell Disease and Thalassemia

Gene Replacement Therapy for Sickle Cell Disease and Other Blood Disorders

Hemoglobin E Syndromes

Limitations of Clinical Trials in Sickle Cell Disease: A Case Study of the Multi-center Study of Hydroxyurea (MSH) Trial and the Stroke Prevention (STOP) Trial

New Insights into Paroxysmal Nocturnal Hemoglobinuria

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only